MUNICH/GENEVA: Novartis AG agreed to buy a 25% stake in Nestle SA's Alcon Inc for US$11bil and said it may acquire the rest to become the world's biggest maker of eye-care products.
Novartis, Switzerland's second-largest pharmaceuticals company, will pay US$143.18 a share for Vevey, Switzerland-based Nestle's 25% holding, and has an option to buy a further 52% from the food company for US$28bil.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!